These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 2475318)
1. [Treatment of stage I-IIB nonseminomatous testicular tumors]. Clemm C; Sauer H; Hartenstein R Dtsch Med Wochenschr; 1989 Aug; 114(34):1276-82. PubMed ID: 2475318 [TBL] [Abstract][Full Text] [Related]
2. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858 [TBL] [Abstract][Full Text] [Related]
3. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival. Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619 [TBL] [Abstract][Full Text] [Related]
4. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis. Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800 [TBL] [Abstract][Full Text] [Related]
5. [Management of stage I testicular nonseminomatous germ cell tumors with an embryonic carcinomatous component. 18 cases]. Drianno N; Robert M; Legouffe E; Guiter J; Navratil H Prog Urol; 1997 Sep; 7(4):622-7. PubMed ID: 9410322 [TBL] [Abstract][Full Text] [Related]
6. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group. Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M; J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of testicular cancer: 10-year experience. Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V; Cársky S Neoplasma; 1993; 40(4):247-53. PubMed ID: 7505886 [TBL] [Abstract][Full Text] [Related]
8. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors (NSGCTT). Ondrus D; Goncalves F; Kausitz J; Mat'oska J; Belan V Neoplasma; 1996; 43(3):195-7. PubMed ID: 8841507 [TBL] [Abstract][Full Text] [Related]
9. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors. Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206 [TBL] [Abstract][Full Text] [Related]
10. [Modified retroperitoneal lymphadenectomy in non-seminomatous stage I, IIa and IIb testicular tumors]. Sparwasser C; Treiber U; Beckert R; Pust RA Urologe A; 1995 Nov; 34(6):444-8. PubMed ID: 8848854 [TBL] [Abstract][Full Text] [Related]
11. Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: a 15-year experience. Cresswell J; Scheitlin W; Gozen A; Lenz E; Teber D; Rassweiler J BJU Int; 2008 Sep; 102(7):844-8. PubMed ID: 18537954 [TBL] [Abstract][Full Text] [Related]
12. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update]. Schmidt P; Haas RJ; Göbel U; Calaminus G Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897 [TBL] [Abstract][Full Text] [Related]
13. [Results of chemotherapy and salvage surgery for advanced testicular cancer]. Saiki S; Meguro N; Maeda O; Kinouchi T; Kuroda M; Usami M; Kotake T; Miki T Hinyokika Kiyo; 1999 Nov; 45(11):777-81. PubMed ID: 10637743 [TBL] [Abstract][Full Text] [Related]
14. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia. Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765 [TBL] [Abstract][Full Text] [Related]
15. Retroperitoneal lymph node dissection in patients with high risk testicular cancer. Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227 [TBL] [Abstract][Full Text] [Related]
16. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89]. Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864 [TBL] [Abstract][Full Text] [Related]
17. [Experiences in the treatment of advanced nonseminomatous testicular tumor]. Scheiber K; Salzer M; Bartsch G Wien Klin Wochenschr; 1986 Aug; 98(15):481-6. PubMed ID: 2429460 [TBL] [Abstract][Full Text] [Related]
18. Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy. Kondagunta GV; Sheinfeld J; Mazumdar M; Mariani TV; Bajorin D; Bacik J; Bosl GJ; Motzer RJ J Clin Oncol; 2004 Feb; 22(3):464-7. PubMed ID: 14752068 [TBL] [Abstract][Full Text] [Related]